| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/26/1996 | CA2215693A1 Tumor marker protein for cancer risk assessment |
| 09/26/1996 | CA2215618A1 Protein production and delivery |
| 09/26/1996 | CA2215525A1 Treatment of papillomavirus-associated lesions using interleukin-12 |
| 09/26/1996 | CA2215449A1 Antisense oligonucleotides for inhibiting helicobacter pylori activity |
| 09/26/1996 | CA2215387A1 Modulators of ob gene and screening methods therefor |
| 09/26/1996 | CA2215162A1 Vectors for gene delivery |
| 09/26/1996 | CA2215122A1 Il-13 receptor specific chimeric proteins and uses thereof |
| 09/26/1996 | CA2215104A1 Compounds and methods for the detection of t. cruzi infection |
| 09/26/1996 | CA2214591A1 Aspergillus arabinofuranosidase |
| 09/26/1996 | CA2214425A1 Endo beta-1,4-glucanase from aspergillus |
| 09/26/1996 | CA2214385A1 Cell culture method |
| 09/26/1996 | CA2211448A1 Rage tumor rejection antigens |
| 09/25/1996 | EP0733905A2 System for nucleic acid based diagnostic assay |
| 09/25/1996 | EP0733903A1 Immunoassay for the detection of urinary cortisol and reagents therefor |
| 09/25/1996 | EP0733714A2 Nucleic acid amplification method and apparatus |
| 09/25/1996 | EP0733713A1 Procedure for measuring the transcription - regulatory activities of DNA-sequences |
| 09/25/1996 | EP0733712A1 Process for producing substance |
| 09/25/1996 | EP0733711A2 Method for cloning and producing the SacI restriction endonuclease |
| 09/25/1996 | EP0733710A1 Process for producing l-lysine by fermentation |
| 09/25/1996 | EP0733709A2 Mutated farnesyldiphosphate synthase capable of synthesizing geranylgeranyldiphosphate and gene coding therefor |
| 09/25/1996 | EP0733708A2 Transferrin-binding protein 1 (Tbp1) gene of Actinobacillus pleuropneumoniae, its use in vaccines for pleuropneumonia and as diagnostic reagents |
| 09/25/1996 | EP0733707A2 Gene participating in the mechanism of secretion of esterase |
| 09/25/1996 | EP0733706A2 Apoptosis-regulating proteins |
| 09/25/1996 | EP0733705A1 Hormone receptor compositions and methods |
| 09/25/1996 | EP0733704A2 Controlable expression system |
| 09/25/1996 | EP0733643A1 Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor |
| 09/25/1996 | EP0733640A1 Double-stranded oligonucleotide and carcinostatic agent containing the same as active ingredient |
| 09/25/1996 | EP0733373A2 Compositions and methods for increasing the immunogenicity of tumor cells by administration of B7 and CD2-transfected cells |
| 09/25/1996 | EP0733370A1 Antagonistic inhibitor against mesenchymal cell growth |
| 09/25/1996 | EP0733369A1 Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors |
| 09/25/1996 | EP0733206A1 Labelling of nucleic acid analogue-peptide chimerae |
| 09/25/1996 | EP0733126A1 Immobilized mismatch binding protein for detection or purification of mutations or polymorphisms |
| 09/25/1996 | EP0733125A1 A representational approach to dna analysis |
| 09/25/1996 | EP0733123A1 Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
| 09/25/1996 | EP0733122A1 Fusion proteins containing adeno-associated virus rep protein and bacterial protein |
| 09/25/1996 | EP0733121A1 Method of synthesizing a fluorescently labeled protein |
| 09/25/1996 | EP0733118A1 Mammal with enhanced liver expression of a transgene |
| 09/25/1996 | EP0733117A1 Chemically regulatable and anti-pathogenic dna sequences and uses thereof |
| 09/25/1996 | EP0733116A1 Method of controlling plant pathogens |
| 09/25/1996 | EP0733115A1 Novel cellulase enzymes and systems for their expression |
| 09/25/1996 | EP0733114A1 CONSTRUCTION OF $i(PASTEURELLA HEAMOLYTICA) VACCINES |
| 09/25/1996 | EP0733113A1 Influenza vaccine |
| 09/25/1996 | EP0733112A1 Cytochrome p-450 monooxygenases |
| 09/25/1996 | EP0733111A1 IFN-$g(g)RECEPTOR $g(b)-CHAIN AND DERIVATIVES THEREOF |
| 09/25/1996 | EP0733110A1 Tuberous sclerosis 2 gene and uses thereof |
| 09/25/1996 | EP0733109A1 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 09/25/1996 | EP0733108A1 Mutants of bone morphogenetic proteins |
| 09/25/1996 | EP0733107A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY |
| 09/25/1996 | EP0733106A1 Plant arabinogalactan protein (agp) genes |
| 09/25/1996 | EP0733105A1 Enhanced transgene expression in specific tissues of the gastrointestinal tract |
| 09/25/1996 | EP0733103A1 Generation of high titers of recombinant aav vectors |
| 09/25/1996 | EP0733102A1 Reagents and methods for the detection of methotrexate |
| 09/25/1996 | EP0733099A1 Process for reducing high-molecular structures |
| 09/25/1996 | EP0733072A1 Antibody against carcinoembryonic antigen (cea) |
| 09/25/1996 | EP0733071A1 Antagonists to chaperonin 10 |
| 09/25/1996 | EP0733070A1 Process for generating specific antibodies |
| 09/25/1996 | EP0733069A1 Purified primate ctla-8 antigens and related reagents |
| 09/25/1996 | EP0733068A1 METHODS AND COMPOSITIONS FOR THE SUPPRESSION OF $i(NEU) MEDIATED TRANSFORMATION |
| 09/25/1996 | EP0733066A1 Pretargeting methods and compounds |
| 09/25/1996 | EP0733064A1 NUCLEIC ACIDS ENCODING A HOUSE DUST MITE ALLERGEN, $i(DER P) III, AND USES THEREFOR |
| 09/25/1996 | EP0733062A1 Protecting nucleic acids and methods of analysis |
| 09/25/1996 | EP0733059A1 Compounds and methods for site-directed mutations in eukaryotic cells |
| 09/25/1996 | EP0733058A1 Nucleic acid mediated electron transfer |
| 09/25/1996 | EP0733057A1 Origin of replication complex genes, proteins and methods |
| 09/25/1996 | EP0732941A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
| 09/25/1996 | EP0732940A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
| 09/25/1996 | EP0732939A1 Preparation and use of immunoconjugates |
| 09/25/1996 | EP0732933A1 Method of treating renal disease by administering igf-i and igfbp-3 |
| 09/25/1996 | EP0732929A1 Therapeutic use of cis-element decoys in vivo |
| 09/25/1996 | EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 09/25/1996 | EP0587805B1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1 |
| 09/25/1996 | EP0578672B1 Thermostable pullulanase |
| 09/25/1996 | EP0511308B1 Chimeric immunoglobulin for cd4 receptors |
| 09/25/1996 | EP0458940B1 Method for the quantitative detection of thyrotropine (tsh) or of anti-thyrotropine receptor autoantibodies (anti-tshr) using a recombinant thyrotropin receptor polypeptide and kit for conducting said method |
| 09/25/1996 | EP0458829B1 Methods and compositions for treatment of cancer using oligonucleotides |
| 09/25/1996 | EP0432249B1 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 09/25/1996 | CN1131970A Glucan elicitor receptor and DNA coding for the same |
| 09/25/1996 | CN1131950A Recombinant C140 receptor and its agonists and antagonists |
| 09/25/1996 | CA2172451A1 Process for the immunologic determination of cortisol, especially urinary cortisol, and reagents used |
| 09/25/1996 | CA2172443A1 Transferrin-binding protein 1 (tbp1) gene of actinobacillus pleuropneumoniae, its use to prepare products for the utilization in vaccines for pleuropneumonia and as diagnostic reagents |
| 09/25/1996 | CA2172210A1 System for nucleic acid based diagnostic assay |
| 09/25/1996 | CA2171668A1 Expression system which can be regulated |
| 09/25/1996 | CA2171059A1 Nucleic acid amplification method and apparatus |
| 09/24/1996 | US5559223 Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants |
| 09/24/1996 | US5559220 Gene encoding acetyl-coenzyme A carboxylase |
| 09/24/1996 | US5559132 Carboxamide derivatives for treating asthma |
| 09/24/1996 | US5559131 Antagonists of tachykinins at the neurokinin 2 receptor, antiasthma |
| 09/24/1996 | US5559099 Penton base protein and methods of using same |
| 09/24/1996 | US5559094 AspB1 insulin analogs |
| 09/24/1996 | US5559034 Synergistic antifungal protein and compositions containing same |
| 09/24/1996 | US5559028 Methods of enhancing or antigen presentation to T cells inhibiting |
| 09/24/1996 | US5559027 Synergistic |
| 09/24/1996 | US5559026 Isolated dna from drosophila and caenorhabditis; genetic engineering |
| 09/24/1996 | US5559025 Expression of mature proteinase 2A, the partial purification thereof and preparation of substrates having an inhibitory effect |
| 09/24/1996 | US5559024 Genetic engineering |
| 09/24/1996 | US5559019 Regulation of splicing of messenger rna precursors, phsophorylation |
| 09/24/1996 | US5559018 Inviable phages, their production and DNA thereof |
| 09/24/1996 | US5559016 Culturing escherichia, corynebacterium or brevibacterium, gene coding for l-alanine dehydrogenase cloned from arthrobacter |
| 09/24/1996 | US5559015 Recombinant-DNA mediated production of xanthan gum |
| 09/24/1996 | US5559013 Complementarity |